Next Article in Journal
The Fate of Oxidative Strand Breaks in Mitochondrial DNA
Next Article in Special Issue
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
Previous Article in Journal
Green Technologies for Persimmon By-Products Revalorisation as Sustainable Sources of Dietary Fibre and Antioxidants for Functional Beverages Development
Previous Article in Special Issue
Antioxidant Activity and Inhibition of Digestive Enzymes of New Strawberry Tree Fruit/Apple Smoothies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Total Antioxidant Capacity, a Diet Quality Index Predicting Mortality Risk in US Adults: Evidence from the NIH-AARP Diet and Health Study

1
Department of Food Science and Nutrition, Jeju National University, Jeju 63243, Republic of Korea
2
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, USA
3
Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
*
Author to whom correspondence should be addressed.
Submission received: 28 March 2023 / Revised: 9 May 2023 / Accepted: 10 May 2023 / Published: 12 May 2023

Abstract

:
Dietary total antioxidant capacity (TAC) is an index representing the total antioxidant power of antioxidants consumed via the diet. This study aimed to investigate the association between dietary TAC and mortality risk in the US adults using data from the NIH-AARP Diet and Health Study. A total of 468,733 adults aged 50–71 years were included. Dietary intake was assessed using a food frequency questionnaire. Dietary TAC from diet was calculated from antioxidants including vitamin C, vitamin E, carotenoids, and flavonoids, and TAC from dietary supplements was calculated from supplemental vitamin C, vitamin E, and beta-carotene. During a median follow-up of 23.1 years, 241,472 deaths were recorded. Dietary TAC was inversely associated with all-cause (hazard ratio (HR) for quintile 5 vs. quintile 1: 0.97, 95% confidence interval (CI): 0.96–0.99, p for trend < 0.0001) and cancer mortality (HR for quintile 5 vs. quintile 1: 0.93, 95% CI: 0.90–0.95, p for trend < 0.0001). However, dietary supplement TAC was inversely associated with cancer mortality risk only. These findings indicate that consuming a habitual diet high in antioxidants may reduce the risk of all-cause and cancer mortality and TAC from foods might confer greater health benefits than TAC from dietary supplements.

1. Introduction

Dietary antioxidants help reduce oxidative stress and inflammation which can lead to several chronic diseases such as diabetes, cardiovascular diseases (CVDs) and cancer [1,2]. Antioxidants including carotenoids, vitamin C, vitamin E, and polyphenols such as flavonoids are concentrated in fruits, vegetables, coffee, tea, and wine [2] and previous epidemiologic studies reported that higher antioxidant intake from these foods is associated with lower mortality risk [3,4,5,6,7,8,9]. Notably, antioxidants have different antioxidant capacities and the combination of those found in foods that are part of our usual diet may have a cumulative or synergic effect [10,11].
Dietary total antioxidant capacity (TAC), which is a concept for assessing total antioxidant power of dietary antioxidants, has received attention due to its potential as a novel predictor of health outcomes. Although dietary TAC has been inversely associated with the risk of diabetes [12,13], CVDs [14,15,16,17], and cancer [18,19,20,21], a recent systematic review study concluded that the association between dietary TAC and mortality risk [22] was inconsistent, which may be due to discrepancies in methods of measuring TAC and consideration of supplemental antioxidant intakes.
Our research team has developed a simple theoretical algorithm that can estimate TAC from all food items in an individual’s diet [11]. This algorithm allows to evaluate dietary TAC just with dietary intake of individuals and has been validated using biomarkers [23,24] and through associations with clinical outcomes [19,25,26,27] and mortality [16,28] in US populations. This protocol was also applied in Korean populations [29] with associations between dietary TAC and diseases such as obesity and osteoporosis [30,31]. Recently, we evaluated the relative validity of dietary TAC compared to previous diet quality indexes, such as the Healthy Eating Index, alternate Mediterranean Diet, and the Dietary Approaches to Stop Hypertension by examining association between diet quality and all-cause mortality among US adults [28]. Therefore, dietary TAC estimated based on our protocols can be a useful diet quality index reflecting antioxidant-rich dietary patterns.
Nevertheless, due to a relatively small number of participants, short follow-up period, and exclusion of antioxidants from dietary supplements in previous studies [16,28], these associations need to be confirmed using data from a large-scale prospective cohort study. Thus, this analysis aimed to investigate the association between dietary TAC including from diet and dietary supplements and all-cause/cause-specific mortality using data from the NIH-AARP Diet and Health Study.

2. Materials and Methods

2.1. Study Population

The NIH-AARP Diet and Health Study is a large prospective cohort study designed to investigate the relationship between diet, lifestyle, and cancer risk. In 1995–1996, a baseline questionnaire assessing dietary intake and lifestyle habits was mailed to 3.5 million American adults aged 50–69 years who resided in one of six states (California, Florida, Pennsylvania, New Jersey, North Carolina, and Louisiana) or in two metropolitan areas (Atlanta, Georgia and Detroit, Michigan). Additional details regarding this study’s design have been described elsewhere [32]. Among 566,398 participants whose baseline data were available, we excluded those who were proxy-responders (n = 15,760), those who had a history of cancer (n = 51,346), those who reported implausible energy intakes (greater than two times the IQR below the 25th percentile or above the 75th percentile (n = 11,860), those with zero years of follow-up (n = 46), and those with a dietary TAC of greater than the 2IQR above the 75th percentile (n = 18,653). A total of 468,733 subjects were included in the final analysis.

2.2. Assessment of Dietary Total Antioxidant Capacity

Dietary TAC was calculated using self-reported diet and dietary supplement intake, respectively, according to the theoretical dietary TAC calculating algorithm [11]. This algorithm simply requires the participants’ antioxidant intakes and antioxidant capacity of each antioxidant compound. Baseline dietary intake was assessed using a 124-item semiquantitative food frequency questionnaire (FFQ) which asked about the intake of foods within the past year, and intakes of antioxidants including carotenoids (β-carotene, α-carotene, β-cryptoxanthin, lutein, zeaxanthin, and lycopene), vitamin C, vitamin E, and flavonoids (4 flavonols, 2 flavones, 3 flavanones, 10 flavan-3-ols, 4 isoflavones, and 6 anthocyanidins) were estimated. Flavonoid intakes were calculated by linking reported dietary intake to the USDA Expanded Flavonoid Database for the Assessment of Dietary Intakes, Release 1.1 [33]. Supplemental antioxidants included β-carotene, vitamin C, and vitamin E, and supplemental antioxidant intakes were assessed based on questions about vitamin supplement use. The antioxidant capacity as vitamin C equivalents (VCE) was previously measured using the 2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS) assay for each antioxidant [11]. For each participant, individual antioxidant capacities were calculated by multiplying the daily intake of individual antioxidants from diet and dietary supplements by their antioxidant capacities. Then, the individual antioxidant capacities were summed up to yield dietary TAC (diet + dietary supplements) [16].

2.3. Case Ascertainment

Participants were followed up from 1995–1996 until the date of death or the end of follow-up (31 December 2019), whichever came first. Vital status was ascertained using the National Death Index. All-cause mortality included mortality from cardiovascular disease (CVD) and cancer, as well as deaths from other circumstances. CVDs included diseases of the heart, hypertension without heart disease, cerebrovascular diseases, atherosclerosis, aortic aneurysm and dissection, and other diseases of arteries, arterioles, and capillaries. Cancer included cancers of oral cavity and pharynx, digestive system, respiratory system, soft tissue including heart, skin excluding basal and squamous, female genital system and breast, male genital system, urinary system, and endocrine system, lymphoma, leukemia, and miscellaneous cancer.

2.4. Assessment of Confounding Variables

Information on confounding variables including sociodemographic variables such as age, sex, race/ethnicity, education level, and marital status, and health-related variables such as body mass index (BMI), physical activity, alcoholic beverage intake, smoking, and history of disease was gathered from baseline questionnaires. Race/ethnicity was categorized into non-Hispanic White, non-Hispanic Black, Hispanic, and other. Education level was classified as less than 11 years, high school graduate, some college or other post-high school training, and college graduate. Marital status was categorized into married, widowed, divorced, or separated, and unmarried. Physical activity was defined as the frequency (never/rarely, 1–3 times/month, 1–2 times/week, 3–4 times/week, and ≥5 times/week) of exercise bouts that increase breathing or heart rate lasting ≥ 20 min in the past 12 months. Alcoholic beverage intake was categorized as none if patients reported never consuming alcohol, low if they reported a non-zero intake below the median among consumers, or high if they reported an intake above the median for consumers. Smoking status was defined as never, former, or current. History of heart disease, stroke, and diabetes was defined as yes or no.

2.5. Statistical Analysis

All statistical analyses were carried out using SAS version 9.4 (SAS Institute, Cary, NC, USA). Dietary TAC, including TAC from diet and supplements, was energy-adjusted using the residual method and was categorized into quintiles, except for TAC from supplements. For TAC from supplements, non-consumers were separated and then consumers were divided into tertiles. Differences in baseline characteristics of study participants according to quintiles of dietary TAC were evaluated using ANOVA for continuous variables or chi-square test for categorical variables. Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality from all-cause, CVD, and cancer-related deaths according to quintiles of dietary TAC. Model 1 was adjusted for age (years, continuous) and sex, and Model 2 was additionally adjusted for race/ethnicity, body mass index (kg/m2, continuous), marital status, alcoholic beverage intake, smoking, physical activity, history of heart disease, stroke, and diabetes, and total energy intake (kcal/day, continuous) based on previous studies [34,35]. The Cox proportional hazard assumption was tested visually for covariates using Schoenfeld residual with no violations. Linear trends across quintiles were evaluated using the median TAC value of each quintile as a continuous variable. Restricted cubic splines were used to illustrate the association between dietary TAC and mortality risk, and HRs and 95% CIs were plotted for dietary TAC with the median value in the lowest quintile as the reference level. For dietary TAC from dietary supplements, zero value was used as the reference level because 32.6% of the subjects were non-consumers. Stratified analyses by age (<65 years/≥65 years), sex (male/female), body weight status (normal/obese), alcoholic beverage intake (none/low/high), and current smoking status (non-current/current) were conducted for TAC from diet only. All p-values were two-sided with α = 0.05 as the significance level.

3. Results

3.1. Baseline Characteristics

Baseline characteristics of study participants according to quintiles of energy-adjusted dietary TAC are presented in Table 1. Participants with higher dietary TAC tended to have lower BMI, higher education level, more frequent physical activity, and lower history of heart disease, stroke, and diabetes (p < 0.0001 for all). In addition, the proportions of subjects with high alcoholic beverage intake and those of current smokers were lowest in the highest quintile group of dietary TAC (p < 0.0001 for all).

3.2. Antioxidant Intakes and TAC

Table 2 shows antioxidant intakes and individual TAC levels from each antioxidant according to dietary TAC. TAC from diet was greater than TAC from supplements within the first and fourth quintile, whereas TAC from supplements was greater than TAC from diet in the highest quintile group. Antioxidants with high contribution to dietary TAC were flavonoids from diet and vitamin C from supplements.

3.3. Association between Dietary TAC and Mortality

During a median follow-up of 23.1 years, 241,472 deaths including 79,011 CVD and 65,733 cancer cases were recorded. Multivariable-adjusted HRs and 95% CIs for mortality according to quintiles of dietary TAC are shown in Table 3. In age- and sex-adjusted models (Model 1), dietary TAC was inversely associated with all-cause mortality (Q5 vs. Q1: HR = 0.83; 95% CI = 0.82–0.84; p for trend < 0.0001) as well as CVD (Q5 vs. Q1: HR = 0.87; 95% CI = 0.86–0.89; p for trend < 0.0001) and cancer mortality (Q5 vs. Q1: HR = 0.80; 95% CI = 0.78–0.82; p for trend < 0.0001). These significant inverse associations remained for cancer mortality in the fully adjusted models (Model 2) with HR of 0.93 (95% CI = 0.90–0.95; p for trend < 0.0001) for the highest quintile compared to the lowest quintile. When dividing TAC sources, TAC from diet was inversely associated with mortality risk, although there was no significant linear trend with CVD mortality. People in the highest tertile of TAC from supplements had a decreased cancer mortality risk (HR = 0.97; 95% CI = 0.95–0.99; p for trend = 0.0190), while they had an increased CVD mortality (HR = 1.03; 95% CI = 1.01–1.05; p for trend = 0.0002) compared to non-consumers in the fully adjusted models.
For dietary TAC including diet and dietary supplements, there were U-shaped associations with all-cause and cancer mortality with lowest HRs at approximately 1200 mg VCE/day (Figure 1). The gradient of the inverse association between dietary TAC from diet only and all-cause and cancer mortality started to decrease at above approximately 800–900 mg VCE/day. There were positive associations between dietary TAC from dietary supplements and all-cause and CVD mortality at above 900–1200 mg VCE/day.

3.4. Stratified Analyses for Association between Dietary TAC from Diet Only and Mortality

For TAC from diet only, stratified analyses for mortality were conducted according to age, sex, body weight status, alcoholic beverage intake, and current smoking status (Table 4). Inverse association between TAC from diet and all-cause and cancer mortality were found in all subgroups except obese subjects for all-cause mortality. Regarding CVD mortality, significant inverse association with TAC from diet was detected in older, female, normal body weight, and non-current smoking subjects as well as subjects with none and high alcoholic beverage intake.

4. Discussion

This large-scale prospective cohort study found that dietary TAC from diet and dietary supplements was inversely associated with the risk of all-cause and cancer mortality. Additionally, people in the highest quintile of TAC from diet had reduced risk of all-cause, CVD, and cancer mortality compared to those in the lowest quintile. However, while people in the highest tertile of TAC from supplements had a decreased risk of cancer mortality, they had an increased risk of CVD mortality compared to non-consumers.
The inverse association between dietary TAC and all-cause mortality in the present study was in line with previous findings of studies on American [16,28], Spanish [3], Swedish [36], French [37], Japanese [17], and Chinese [14] populations, although no significant association was reported in Spanish elderly subjects at high cardiovascular risk [38]. A recent meta-analysis of five prospective studies also found significant inverse associations between dietary TAC and the risk of all-cause, CVD, and cancer mortality [39]. Considering that dietary TAC has been consistently associated with mortality regardless of methodological disparities in TAC assessments (e.g., ferric reducing antioxidant power (FRAP) and oxygen radical absorbance capacity (ORAC) assays), dietary TAC can be a valuable predictor of health outcomes such as mortality.
Notably, in this study, the associations of dietary TAC differed by the TAC sources, especially for CVD mortality. Dietary supplements were major sources of TAC in US adults [40], but effects of supplemental antioxidants on cardiovascular health are controversial. Several studies reported no significant effect of antioxidant supplements on the risk of CVD [41,42,43,44]. According to a recent meta-analysis of randomized controlled intervention trials, supplementation of vitamins C and E was not associated with CVD risk, while β-carotene supplementation was associated with increased all-cause mortality including CVD mortality [44]. Dietary and supplemental TAC showed consistent inverse relationships with cancer mortality in this study; however, in a prospective study based on the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [18], a risk reduction of pancreatic cancer mortality was observed in TAC from diet, not TAC from supplements. In addition, antioxidant supplement use was not associated with cancer and non-cancer mortality based on the UK Biobank cohort study [45]. These findings indicate that the combination of antioxidants and synergistic effects of other compounds may be contained without the food matrix.
Study participants with higher dietary TAC consumed greater amounts of all types of antioxidants from diet and dietary supplements, which reflects a high diet quality. In our previous study, US adults with higher dietary TAC generally had higher adherence to diet quality indexes; they tended to consume greater amounts of whole fruits, dark green vegetables, whole grains, legumes, and nuts and seeds, as well as seafood [28]. Correlation between dietary TAC and diet quality has been confirmed in other studies as well [46,47,48]. Therefore, we cannot rule out the possibility that reduced risk of all-cause and cancer mortality according to dietary TAC might be resulted from overall healthy dietary pattern of people with high dietary TAC.
In a stratified analysis, TAC from diet was significantly inversely associated with cancer mortality in all subgroups. Significant inverse associations with CVD mortality were observed in older, female, and normal body weight, and in non-current smoking subjects as well as non-drinkers and those with high alcoholic beverage intakes. Although it is difficult to identify reasons for the differential associations with CVD mortality following stratification of participants on lifestyle factors in this study, one plausible explanation is that increased oxidative stress levels caused by obesity [49] and smoking [50] may attenuate the beneficial effect of dietary antioxidants on CVD.
Although there were statistically significant associations between dietary TAC and mortality risk, the effect size was relatively small compared to an increase in dietary TAC. For example, people in the highest quintile of dietary TAC had about seven times higher dietary TAC compared to those in the lowest quintile, but they had a 3% decreased risk of all-cause mortality. This might be partly due to the wide range of dietary TAC with right-skewed distributions, and therefore the associations should be interpreted with changes in dietary TAC. Moreover, restricted cubic spline curves indicated that there were U-shaped associations between dietary TAC and all-cause and cancer mortality and the gradient of the inverse association between TAC from diet only and all-cause and cancer mortality decreased from above a specific point. Further studies are required to investigate the optimal levels of dietary antioxidants and TAC with considerations of serum antioxidants, bioavailability of antioxidants, and interaction with other nutrients.
To the best of our knowledge, this is the first study investigating the association between theoretical dietary TAC from diet and dietary supplements and mortality from all causes, CVD, and cancer using data from a large-scale prospective study with a long follow-up. However, this study has some limitations. First, dietary intake measured at single point (baseline) may not reflect the cumulative average intake. Although dietary TAC might have changed over time due to changes in eating behavior, food supply, and/or perceptions of what is considered healthy, according to studies with long-term prospective cohorts, the dietary intake data obtained from the FFQ at baseline reflect longer-term dietary quality and are linked to diet-related health risk [51,52,53]. In addition, using only the earliest dietary measure may be appropriate to examine hypothetical associations between dietary exposures and diseases with a long latency [54]. Second, dietary TAC estimated in this study does not reflect an individual’s bioavailability of antioxidants; however, we previously validated its correlation with a body’s antioxidant status in populations with various physiological conditions [25,55]. Third, dietary TAC may be underestimated because proanthocyanidines and other polyphenols were not calculated in this study. Fourth, because many of the participants were non-Hispanic white, it may be difficult to generalize the findings to other populations with different race/ethnicity. Lastly, there might be unmeasured residual confounding.

5. Conclusions

This study found that dietary TAC from diet and dietary supplements was associated with mortality risk using data from a large longitudinal study. Although both TAC from diet and supplements may decrease all-cause and cancer-related deaths, TAC from foods might confer greater health benefits than TAC from dietary supplements. Further studies are required to establish recommendations of appropriate levels of dietary antioxidants such as flavonoids and TAC.

Author Contributions

Conceptualization, K.H. and O.K.C.; methodology, K.H. and O.K.C.; formal analysis, K.H.; investigation, K.H., L.M.L., R.S. and O.K.C.; data curation, L.M.L. and R.S.; writing—original draft preparation, K.H.; writing—review and editing, L.M.L., R.S. and O.K.C.; supervision, O.K.C.; project administration, O.K.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The NIH-AARP Diet and Health Study was reviewed and approved by the Special Studies Institutional Review Board of the US National Cancer Institute.

Informed Consent Statement

All participants gave written informed consent by virtue of completing and returning the questionnaire.

Data Availability Statement

Data were obtained from the National Cancer Institute and are available for established researchers by submitting a project proposal to https://www.nihaarpstars.com (accessed on 29 June 2020).

Acknowledgments

This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute. Cancer incidence data from the Atlanta metropolitan area were collected by the Georgia Center for Cancer Statistics, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. Cancer incidence data from California were collected by the California Cancer Registry, California Department of Public Health’s Cancer Surveillance and Research Branch, Sacramento, California. Cancer incidence data from the Detroit metropolitan area were collected by the Michigan Cancer Surveillance Program, Community Health Administration, Lansing, Michigan. The Florida cancer incidence data used in this report were collected by the Florida Cancer Data System (Miami, Florida) under contract with the Florida Department of Health, Tallahassee, Florida. The views expressed herein are solely those of the authors and do not necessarily reflect those of the FCDC or FDOH. Cancer incidence data from Louisiana were collected by the Louisiana Tumor Registry, Louisiana State University Health Sciences Center School of Public Health, New Orleans, Louisiana. Cancer incidence data from New Jersey were collected by the New Jersey State Cancer Registry, The Rutgers. Cancer Institute of New Jersey, New Brunswick, New Jersey. Cancer incidence data from North Carolina were collected by the North Carolina Central Cancer Registry, Raleigh, North Carolina. Cancer incidence data from Pennsylvania were supplied by the Division of Health Statistics and Research, Pennsylvania Department of Health, Harrisburg, Pennsylvania. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. Cancer incidence data from Arizona were collected by the Arizona Cancer Registry, Division of Public Health Services, Arizona Department of Health Services, Phoenix, Arizona. Cancer incidence data from Texas were collected by the Texas Cancer Registry, Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas. Cancer incidence data from Nevada were collected by the Nevada Central Cancer Registry, Division of Public and Behavioral Health, State of Nevada Department of Health and Human Services, Carson City, Nevada. We are indebted to the participants in the NIH-AARP Diet and Health Study for their outstanding cooperation. We wish to acknowledge Arthur Schatzkin who was instrumental in conceiving and establishing the NIH-AARP Diet and Health Study. We also thank former and current study leaders at the National Cancer Institute and AARP, including Louise A. Brinton, Laurence S. Freedman, Albert R. Hollenbeck, Victor Kipnis, Michael F. Leitzmann, Linda M. Liao, Charles E. Matthews, Yikyung Park, Rashmi Sinha, Amy F. Subar and Mary H. Ward. Additionally, we are thankful to Sigurd Hermansen and Kerry Grace Morrissey from Westat for study outcomes ascertainment and management and Leslie Carroll and her team at Information Management Services for data support and analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Arulselvan, P.; Fard, M.T.; Tan, W.S.; Gothai, S.; Fakurazi, S.; Norhaizan, M.E.; Kumar, S.S. Role of Antioxidants and Natural Products in Inflammation. Oxid. Med. Cell. Longev. 2016, 2016, 5276130. [Google Scholar] [CrossRef] [PubMed]
  2. Da Costa, L.A.; Badawi, A.; El-Sohemy, A. Nutrigenetics and modulation of oxidative stress. Ann. Nutr. Metab. 2012, 60 (Suppl. S3), 27–36. [Google Scholar] [CrossRef] [PubMed]
  3. Agudo, A.; Cabrera, L.; Amiano, P.; Ardanaz, E.; Barricarte, A.; Berenguer, T.; Chirlaque, M.D.; Dorronsoro, M.; Jakszyn, P.; Larrañaga, N.; et al. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: Findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am. J. Clin. Nutr. 2007, 85, 1634–1642. [Google Scholar] [CrossRef]
  4. Jayedi, A.; Rashidy-Pour, A.; Parohan, M.; Zargar, M.S.; Shab-Bidar, S. Dietary Antioxidants, Circulating Antioxidant Concentrations, Total Antioxidant Capacity, and Risk of All-Cause Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Observational Studies. Adv. Nutr. 2018, 9, 701–716. [Google Scholar] [CrossRef] [PubMed]
  5. Bondonno, N.P.; Dalgaard, F.; Kyrø, C.; Murray, K.; Bondonno, C.P.; Lewis, J.R.; Croft, K.D.; Gislason, G.; Scalbert, A.; Cassidy, A.; et al. Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort. Nat. Commun. 2019, 10, 3651. [Google Scholar] [CrossRef]
  6. Ha, K.; Sakaki, J.R.; Chun, O.K. Nutrient Adequacy Is Associated with Reduced Mortality in US Adults. J. Nutr. 2021, 151, 3214–3222. [Google Scholar] [CrossRef]
  7. Chen, Z.; Huang, Y.; Cao, D.; Qiu, S.; Chen, B.; Li, J.; Bao, Y.; Wei, Q.; Han, P.; Liu, L. Vitamin C Intake and Cancers: An Umbrella Review. Front. Nutr. 2021, 8, 812394. [Google Scholar] [CrossRef]
  8. Kim, Y.; Je, Y. Flavonoid intake and mortality from cardiovascular disease and all causes: A meta-analysis of prospective cohort studies. Clin. Nutr. ESPEN 2017, 20, 68–77. [Google Scholar] [CrossRef]
  9. Ivey, K.L.; Hodgson, J.M.; Croft, K.D.; Lewis, J.R.; Prince, R.L. Flavonoid intake and all-cause mortality. Am. J. Clin. Nutr. 2015, 101, 1012–1020. [Google Scholar] [CrossRef]
  10. Serafini, M.; Del Rio, D. Understanding the association between dietary antioxidants, redox status and disease: Is the Total Antioxidant Capacity the right tool? Redox Rep. 2004, 9, 145–152. [Google Scholar] [CrossRef]
  11. Floegel, A.; Kim, D.O.; Chung, S.J.; Song, W.O.; Fernandez, M.L.; Bruno, R.S.; Koo, S.I.; Chun, O.K. Development and validation of an algorithm to establish a total antioxidant capacity database of the US diet. Int. J. Food. Sci. Nutr. 2010, 61, 600–623. [Google Scholar] [CrossRef] [PubMed]
  12. Psaltopoulou, T.; Panagiotakos, D.B.; Pitsavos, C.; Chrysochoou, C.; Detopoulou, P.; Skoumas, J.; Stefanadis, C. Dietary antioxidant capacity is inversely associated with diabetes biomarkers: The ATTICA study. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 561–567. [Google Scholar] [CrossRef] [PubMed]
  13. Cyuńczyk, M.; Zujko, M.E.; Jamiołkowski, J.; Zujko, K.; Łapińska, M.; Zalewska, M.; Kondraciuk, M.; Witkowska, A.M.; Kamiński, K.A. Dietary Total Antioxidant Capacity Is Inversely Associated with Prediabetes and Insulin Resistance in Bialystok PLUS Population. Antioxidants 2022, 11, 283. [Google Scholar] [CrossRef] [PubMed]
  14. Sheng, L.T.; Jiang, Y.W.; Pan, A.; Koh, W.P. Dietary total antioxidant capacity and mortality outcomes: The Singapore Chinese Health Study. Eur. J. Nutr. 2022, 61, 2375–2382. [Google Scholar] [CrossRef]
  15. Rautiainen, S.; Levitan, E.B.; Mittleman, M.A.; Wolk, A. Total antioxidant capacity of diet and risk of heart failure: A population-based prospective cohort of women. Am. J. Med. 2013, 126, 494–500. [Google Scholar] [CrossRef]
  16. Kim, K.; Vance, T.M.; Chen, M.H.; Chun, O.K. Dietary total antioxidant capacity is inversely associated with all-cause and cardiovascular disease death of US adults. Eur. J. Nutr. 2018, 57, 2469–2476. [Google Scholar] [CrossRef]
  17. Kashino, I.; Mizoue, T.; Serafini, M.; Akter, S.; Sawada, N.; Ishihara, J.; Kotemori, A.; Inoue, M.; Yamaji, T.; Goto, A.; et al. Higher Dietary Non-enzymatic Antioxidant Capacity Is Associated with Decreased Risk of All-Cause and Cardiovascular Disease Mortality in Japanese Adults. J. Nutr. 2019, 149, 1967–1976. [Google Scholar] [CrossRef]
  18. Zhong, G.C.; Pu, J.Y.; Wu, Y.L.; Yi, Z.J.; Wan, L.; Wang, K.; Hao, F.B.; Zhao, Y.; Gong, J.P. Total Antioxidant Capacity and Pancreatic Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomark. Prev. 2020, 29, 1019–1028. [Google Scholar] [CrossRef]
  19. Vance, T.M.; Wang, Y.; Su, L.J.; Fontham, E.T.; Steck, S.E.; Arab, L.; Bensen, J.T.; Mohler, J.L.; Chen, M.H.; Chun, O.K. Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study. Nutr. Cancer 2016, 68, 214–224. [Google Scholar] [CrossRef]
  20. Lucas, A.L.; Bosetti, C.; Boffetta, P.; Negri, E.; Tavani, A.; Serafini, M.; Polesel, J.; Serraino, D.; La Vecchia, C.; Rossi, M. Dietary total antioxidant capacity and pancreatic cancer risk: An Italian case-control study. Br. J. Cancer 2016, 115, 102–107. [Google Scholar] [CrossRef]
  21. Pantavos, A.; Ruiter, R.; Feskens, E.F.; de Keyser, C.E.; Hofman, A.; Stricker, B.H.; Franco, O.H.; Kiefte-de Jong, J.C. Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The Rotterdam Study. Int. J. Cancer 2015, 136, 2178–2186. [Google Scholar] [CrossRef] [PubMed]
  22. Das, A.; Hsu, M.S.H.; Rangan, A.; Hirani, V. Dietary or supplemental intake of antioxidants and the risk of mortality in older people: A systematic review. Nutr. Diet. 2021, 78, 24–40. [Google Scholar] [CrossRef] [PubMed]
  23. Wang, Y.; Yang, M.; Lee, S.G.; Davis, C.; Masterjohn, C.; Kenny, A.; Bruno, R.S.; Chun, O.K. Total Antioxidant Capacity: A Useful Tool in Assessing Antioxidant Intake Status. In Natural Compounds as Inducers of Cell Death; Diederich, M., Noworyta, K., Eds.; Springer: Amsterdam, The Netherlands, 2012; Volume 1, pp. 265–292. [Google Scholar]
  24. Chun, O.K.; Chung, S.J.; Song, W.O. Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J. Am. Diet. Assoc. 2009, 109, 245–254. [Google Scholar] [CrossRef]
  25. Wang, Y.; Yang, M.; Lee, S.G.; Davis, C.G.; Koo, S.I.; Chun, O.K. Dietary total antioxidant capacity is associated with diet and plasma antioxidant status in healthy young adults. J. Acad. Nutr. Diet. 2012, 112, 1626–1635. [Google Scholar] [CrossRef] [PubMed]
  26. Wang, Y.; Yang, M.; Lee, S.G.; Davis, C.G.; Koo, S.I.; Fernandez, M.L.; Volek, J.S.; Chun, O.K. Diets high in total antioxidant capacity improve risk biomarkers of cardiovascular disease: A 9-month observational study among overweight/obese postmenopausal women. Eur. J. Nutr. 2014, 53, 1363–1369. [Google Scholar] [CrossRef] [PubMed]
  27. Kim, K.; Vance, T.M.; Chun, O.K. Greater Total Antioxidant Capacity from Diet and Supplements Is Associated with a Less Atherogenic Blood Profile in U.S. Adults. Nutrients 2016, 8, 15. [Google Scholar] [CrossRef]
  28. Ha, K.; Kim, K.; Sakaki, J.R.; Chun, O.K. Relative Validity of Dietary Total Antioxidant Capacity for Predicting All-Cause Mortality in Comparison to Diet Quality Indexes in US Adults. Nutrients 2020, 12, 1210. [Google Scholar] [CrossRef]
  29. Jun, S.; Chun, O.K.; Joung, H. Estimation of dietary total antioxidant capacity of Korean adults. Eur. J. Nutr. 2018, 57, 1615–1625. [Google Scholar] [CrossRef]
  30. Kim, S.; Song, Y.; Lee, J.E.; Jun, S.; Shin, S.; Wie, G.A.; Cho, Y.H.; Joung, H. Total Antioxidant Capacity from Dietary Supplement Decreases the Likelihood of Having Metabolic Syndrome in Korean Adults. Nutrients 2017, 9, 1055. [Google Scholar] [CrossRef]
  31. Kim, D.; Han, A.; Park, Y. Association of Dietary Total Antioxidant Capacity with Bone Mass and Osteoporosis Risk in Korean Women: Analysis of the Korea National Health and Nutrition Examination Survey 2008–2011. Nutrients 2021, 13, 1149. [Google Scholar] [CrossRef]
  32. Schatzkin, A.; Subar, A.F.; Thompson, F.E.; Harlan, L.C.; Tangrea, J.; Hollenbeck, A.R.; Hurwitz, P.E.; Coyle, L.; Schussler, N.; Michaud, D.S.; et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am. J. Epidemiol. 2001, 154, 1119–1125. [Google Scholar] [CrossRef] [PubMed]
  33. Bhagwat, S.; Haytowitz, D.B.; Wasswa-Kintu, S. USDA’s Expanded Flavonoid Database for the Assessment of Dietary Intakes, Release 1.1; Nutrient Data Laboratory; Beltsville Human Nutrition Research Center; ARS; USDA: Beltsville, MD, USA, 2015.
  34. Kim, K.; Vance, T.M.; Chun, O.K. Estimated intake and major food sources of flavonoids among US adults: Changes between 1999–2002 and 2007–2010 in NHANES. Eur. J. Nutr. 2016, 55, 833–843. [Google Scholar] [CrossRef] [PubMed]
  35. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022, 400, 563–591. [Google Scholar] [CrossRef] [PubMed]
  36. Michaëlsson, K.; Wolk, A.; Melhus, H.; Byberg, L. Milk, Fruit and Vegetable, and Total Antioxidant Intakes in Relation to Mortality Rates: Cohort Studies in Women and Men. Am. J. Epidemiol. 2017, 185, 345–361. [Google Scholar] [CrossRef] [PubMed]
  37. Bastide, N.; Dartois, L.; Dyevre, V.; Dossus, L.; Fagherazzi, G.; Serafini, M.; Boutron-Ruault, M.C. Dietary antioxidant capacity and all-cause and cause-specific mortality in the E3N/EPIC cohort study. Eur. J. Nutr. 2017, 56, 1233–1243. [Google Scholar] [CrossRef]
  38. Henríquez-Sánchez, P.; Sánchez-Villegas, A.; Ruano-Rodríguez, C.; Gea, A.; Lamuela-Raventós, R.M.; Estruch, R.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Schröder, H.; et al. Dietary total antioxidant capacity and mortality in the PREDIMED study. Eur. J. Nutr. 2016, 55, 227–236. [Google Scholar] [CrossRef]
  39. Parohan, M.; Anjom-Shoae, J.; Nasiri, M.; Khodadost, M.; Khatibi, S.R.; Sadeghi, O. Dietary total antioxidant capacity and mortality from all causes, cardiovascular disease and cancer: A systematic review and dose-response meta-analysis of prospective cohort studies. Eur. J. Nutr. 2019, 58, 2175–2189. [Google Scholar] [CrossRef]
  40. Yang, M.; Chung, S.J.; Chung, C.E.; Kim, D.O.; Song, W.O.; Koo, S.I.; Chun, O.K. Estimation of total antioxidant capacity from diet and supplements in US adults. Br. J. Nutr. 2011, 106, 254–263. [Google Scholar] [CrossRef]
  41. Myung, S.K.; Ju, W.; Cho, B.; Oh, S.W.; Park, S.M.; Koo, B.K.; Park, B.J. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: Systematic review and meta-analysis of randomised controlled trials. BMJ 2013, 346, f10. [Google Scholar] [CrossRef]
  42. Czernichow, S.; Bertrais, S.; Blacher, J.; Galan, P.; Briançon, S.; Favier, A.; Safar, M.; Hercberg, S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: Association with plasma antioxidant levels. J. Hypertens. 2005, 23, 2013–2018. [Google Scholar] [CrossRef]
  43. Leopold, J.A. Antioxidants and coronary artery disease: From pathophysiology to preventive therapy. Coron. Artery Dis. 2015, 26, 176–183. [Google Scholar] [CrossRef] [PubMed]
  44. An, P.; Wan, S.; Luo, Y.; Luo, J.; Zhang, X.; Zhou, S.; Xu, T.; He, J.; Mechanick, J.I.; Wu, W.C.; et al. Micronutrient Supplementation to Reduce Cardiovascular Risk. J. Am. Coll. Cardiol. 2022, 80, 2269–2285. [Google Scholar] [CrossRef] [PubMed]
  45. Behrendt, I.; Eichner, G.; Fasshauer, M. Association of Antioxidants Use with All-Cause and Cause-Specific Mortality: A Prospective Study of the UK Biobank. Antioxidants 2020, 9, 1287. [Google Scholar] [CrossRef] [PubMed]
  46. Salari-Moghaddam, A.; Nouri-Majd, S.; Keshteli, A.H.; Emami, F.; Esmaillzadeh, A.; Adibi, P. Association between Dietary Total Antioxidant Capacity and Diet Quality in Adults. Front. Nutr. 2022, 9, 838752. [Google Scholar] [CrossRef]
  47. Puchau, B.; Zulet, M.A.; de Echávarri, A.G.; Hermsdorff, H.H.; Martínez, J.A. Dietary total antioxidant capacity: A novel indicator of diet quality in healthy young adults. J. Am. Coll. Nutr. 2009, 28, 648–656. [Google Scholar] [CrossRef]
  48. Zujko, M.E.; Waśkiewicz, A.; Witkowska, A.M.; Cicha-Mikołajczyk, A.; Zujko, K.; Drygas, W. Dietary Total Antioxidant Capacity-A New Indicator of Healthy Diet Quality in Cardiovascular Diseases: A Polish Cross-Sectional Study. Nutrients 2022, 14, 3219. [Google Scholar] [CrossRef]
  49. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2017, 114, 1752–1761. [Google Scholar] [CrossRef]
  50. van der Vaart, H.; Postma, D.S.; Timens, W.; ten Hacken, N.H. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 2004, 59, 713–721. [Google Scholar] [CrossRef]
  51. Nomura, A.; Hankin, J.; Rhoads, G. The reproducibility of dietary intake data in a prospective study of gastrointestinal cancer. Am. J. Clin. Nutr. 1976, 29, 1432–1436. [Google Scholar] [CrossRef]
  52. Newby, P.; Weismayer, C.; Akesson, A.; Tucker, K.; Wolk, A. Long-term stability of food patterns identified by use of factor analysis among Swedish women. J. Nutr. 2006, 136, 626–633. [Google Scholar] [CrossRef]
  53. Park, S.; Boushey, C.; Wilkens, L.; Haiman, C.; Le Marchand, L. High-quality diets associate with reduced risk of colorectal cancer: Analyses of diet quality indexes in the Multiethnic Cohort. Gastroenterology 2017, 153, 386–394. [Google Scholar] [CrossRef] [PubMed]
  54. Willett, W. Issues in Analysis and Presentation of Dietary Data. In Nutritional Epidemiology, 3rd ed.; Oxford University Press: New York, NY, USA, 2013; pp. 316–317. [Google Scholar]
  55. Wang, Y.; Yang, M.; Lee, S.G.; Davis, C.G.; Kenny, A.; Koo, S.I.; Chun, O.K. Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women. J. Nutr. Biochem. 2012, 23, 1725–1731. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Hazard ratios from Cox proportional hazard regression models with restricted cubic spline curves describing the association between dietary TAC (from diet and dietary supplements (first column, reference level = 221.2 mg VCE/day), diet only (second column, reference level = 170.6 mg VCE/day), and dietary supplements only (third column, reference level = 0 mg VCE/day)) and all-cause (A), CVD (B), and cancer (C) mortality. Models included age, sex, race/ethnicity, body mass index, marital status, alcoholic beverage intake, smoking, physical activity, history of heart disease, stroke, and diabetes, and total energy intake.
Figure 1. Hazard ratios from Cox proportional hazard regression models with restricted cubic spline curves describing the association between dietary TAC (from diet and dietary supplements (first column, reference level = 221.2 mg VCE/day), diet only (second column, reference level = 170.6 mg VCE/day), and dietary supplements only (third column, reference level = 0 mg VCE/day)) and all-cause (A), CVD (B), and cancer (C) mortality. Models included age, sex, race/ethnicity, body mass index, marital status, alcoholic beverage intake, smoking, physical activity, history of heart disease, stroke, and diabetes, and total energy intake.
Antioxidants 12 01086 g001
Table 1. Baseline characteristics of study participants according to energy-adjusted dietary total antioxidant capacity.
Table 1. Baseline characteristics of study participants according to energy-adjusted dietary total antioxidant capacity.
CharacteristicsEnergy-Adjusted Dietary Total Antioxidant Capacity (Diet + Dietary Supplements)
Quintile 1
(n = 93,746)
Quintile 2
(n = 93,747)
Quintile 3
(n = 93,747)
Quintile 4
(n = 93,747)
Quintile 5
(n = 93,746)
p Value
Age (years)61.3 ± 5.4 161.6 ± 5.461.6 ± 5.461.7 ± 5.461.5 ± 5.3<0.0001
BMI (kg/m2)27.5 ± 5.127.3 ± 5.027.2 ± 5.126.9 ± 5.026.5 ± 5.1<0.0001
Energy intake (kcal/day)1688.7 ± 718.11782.2 ± 697.21850.7 ± 711.61833.2 ± 689.51639.0 ± 640.4<0.0001
Sex <0.0001
Male62,626 (66.8)58,054 (61.9)55,475 (59.2)53,540 (57.1)48,668 (51.9)
Female31,120 (33.2)35,693 (38.1)38,272 (40.8)40,207 (42.9)45,078 (48.1)
Race/ethnicity <0.0001
Non-Hispanic White85,786 (93.0)86,061 (93.0)84,796 (91.7)84,936 (91.9)86,599 (93.5)
Non-Hispanic Black3485 (3.8)3672 (4.0)4188 (4.5)3925 (4.3)2595 (2.8)
Hispanic1791 (1.9)1643 (1.8)1886 (2.0)1828 (2.0)1735 (1.9)
Other1196 (1.3)1184 (1.3)1624 (1.8)1722 (1.9)1668 (1.8)
Education <0.0001
Less than 11 years7431 (8.2)5792 (6.4)5426 (6.0)5284 (5.8)3673 (4.0)
High school graduate21,687 (23.9)19,172 (21.0)18,275 (20.1)17,631 (19.4)14,838 (16.3)
Some college or other post-HS training31,917 (35.1)30,674 (33.6)30,723 (33.8)30,573 (33.7)30,986 (34.0)
College graduate29,853 (32.9)35,588 (39.0)36,561 (40.2)37,310 (41.1)41,553 (45.6)
Marital status <0.0001
Married67,319 (72.6)66,503 (71.5)64,443 (69.3)63,113 (67.9)60,051 (64.5)
Widowed, divorced, or separated21,492 (23.2)22,303 (24.0)24,036 (25.9)25,174 (27.1)28,129 (30.2)
Unmarried3931 (4.2)4230 (4.6)4496 (4.8)4676 (5.0)4932 (5.3)
Physical activity 2 <0.0001
Never/rarely23,095 (25.0)17,286 (18.6)16,076 (17.4)14,875 (16.0)13,109 (14.1)
1–3 times/mo15,224 (16.5)13,361 (14.4)12,681 (13.7)11,664 (12.6)10,975 (11.8)
1–2 times/wk20,248 (21.9)21,030 (22.7)20,457 (22.1)20,217 (21.8)19,172 (20.6)
3–4 times/wk20,475 (22.2)24,709 (26.7)25,538 (27.6)26,681 (28.8)28,176 (30.3)
≥5 times/wk13,336 (14.4)16,338 (17.6)17,906 (19.3)19,273 (20.8)21,535 (23.2)
Alcoholic beverage intake (g/day) 3 <0.0001
None45,378 (48.4)43,092 (46.0)43,620 (46.5)43,563 (46.5)44,492 (47.5)
Low21,907 (23.4)24,256 (25.9)25,013 (26.7)25,300 (27.0)25,245 (26.9)
High26,461 (28.2)26,399 (28.2)25,114 (26.8)24,884 (26.5)24,009 (25.6)
Smoking <0.0001
Never27,304 (30.3)32,620 (36.2)34,740 (38.6)35,128 (38.9)34,667 (38.4)
Former46,171 (51.3)46,963 (52.0)45,523 (50.5)45,511 (50.5)46,877 (51.9)
Current16,532 (18.4)10,657 (11.8)9835 (10.9)9563 (10.6)8832 (9.8)
History of heart disease <0.0001
No80,430 (85.8)80,351 (85.7)80,781 (86.2)80,885 (86.3)81,261 (86.7)
Yes13,316 (14.2)13,396 (14.3)12,966 (13.8)12,862 (13.7)12,485 (13.3)
History of stroke <0.0001
No91,455 (97.6)91,767 (97.9)91,792 (97.9)91,860 (98.0)92,094 (98.2)
Yes2291 (2.4)1980 (2.1)1955 (2.1)1887 (2.0)1652 (1.8)
History of diabetes <0.0001
No83,932 (89.5)84,622 (90.3)85,179 (90.9)85,707 (91.4)86,758 (92.6)
Yes9814 (10.5)9125 (9.7)8568 (9.1)8040 (8.6)6988 (7.5)
1 All values are presented as mean ± SD or n (%). 2 Physical activities lasted for ≥20 min in the past 12 months that caused increases in breathing or heart rate or worked up a sweat. 3 Alcoholic beverage intake was divided equally in half (low or high) among alcoholic beverage drinkers.
Table 2. Antioxidant intakes according to energy-adjusted dietary total antioxidant capacity.
Table 2. Antioxidant intakes according to energy-adjusted dietary total antioxidant capacity.
AntioxidantEnergy-Adjusted Dietary Total Antioxidant Capacity (Diet + Dietary Supplements)
Quintile 1
(n = 93,746)
Quintile 2
(n = 93,747)
Quintile 3
(n = 93,747)
Quintile 4
(n = 93,747)
Quintile 5
(n = 93,746)
From diet
Alpha-carotene (μg)589.7 ± 731.7858.6 ± 1018.51012.8 ± 1209.61063.1 ± 1305.61117.9 ± 1418.1
Beta-carotene (μg)2630.2 ± 21613786 ± 3043.74503.7 ± 37574705.9 ± 4178.34822.1 ± 4353.8
Beta-cryptoxanthin (μg)90.1 ± 59.8165.8 ± 93.4221.1 ± 140.3237 ± 189.5224.1 ± 177.3
Lutein + zeaxanthin (μg)1920.3 ± 1559.42728.6 ± 2278.83251.6 ± 28763371.8 ± 3221.83379.9 ± 3247.2
Lycopene (μg)5568.7 ± 4430.56895.8 ± 5641.27705.9 ± 69847802.4 ± 7749.87426.8 ± 7454.4
Vitamin E (mg)6.3 ± 3.17.1 ± 3.47.5 ± 3.57.5 ± 3.56.9 ± 3.3
Vitamin C (mg)81.5 ± 38.5136.2 ± 57.4174.9 ± 87.2184.6 ± 116.7175.4 ± 109.4
Flavonoids (mg)54.6 ± 25.3103.4 ± 36.6154.3 ± 62.5179.7 ± 109.5176.3 ± 117.5
Flavonols11.9 ± 6.817.1 ± 8.222.4 ± 10.424.9 ± 14.324.5 ± 14.9
Flavones0.6 ± 0.40.9 ± 0.61.1 ± 0.91.2 ± 1.01.2 ± 1.0
Flavanones15.4 ± 14.434.8 ± 24.449.5 ± 3753.8 ± 50.950.3 ± 47.6
Flavan-3-ols19.5 ± 14.338.3 ± 29.765.6 ± 51.783.5 ± 86.783.7 ± 95.8
Anthocyanidins6.8 ± 6.711.8 ± 10.915.3 ± 15.216.0 ± 17.216.1 ± 16.4
Isoflavones0.4 ± 0.30.4 ± 0.30.4 ± 0.30.4 ± 0.30.3 ± 0.3
From dietary supplements
Beta-carotene (μg)166.1 ± 379.9335.5 ± 527.3494.6 ± 695.0886.0 ± 1125.71525.8 ± 1626.4
Vitamin E (a-TE) 11.7 ± 40.729.4 ± 67.248.5 ± 83.693.7 ± 99.5168.7 ± 119.9
Vitamin C (mg)15.3 ± 29.640.1 ± 55.299.8 ± 129.7351.6 ± 250982.1 ± 420.8
Total antioxidant capacity
(mg VCE)
205.0 ± 73.6375.4 ± 79.7574.6 ± 123.3899.8 ± 182.11537.9 ± 379.9
From diet186.4 ± 73.2327.1 ± 97.4461.4 ± 162.5522.2 ± 273.6509.0 ± 283.9
From carotenoids4.5 ± 3.05.8 ± 3.96.6 ± 4.86.7 ± 5.46.5 ± 5.2
From vitamin E1.7 ± 0.92.0 ± 0.92.1 ± 1.02.1 ± 1.01.9 ± 0.9
From vitamin C81.5 ± 38.5136.2 ± 57.4174.9 ± 87.2184.6 ± 116.7175.4 ± 109.4
From flavonoids98.8 ± 46.3183.2 ± 73.6277.9 ± 126.9328.8 ± 222.2325.2 ± 242.8
From dietary supplements18.6 ± 33.848.3 ± 61.6113.2 ± 136.8377.6 ± 261.61028.8 ± 432.1
From beta-carotene0.04 ± 0.100.08 ± 0.130.12 ± 0.180.22 ± 0.280.38 ± 0.41
From vitamin E3.2 ± 11.28.1 ± 18.513.3 ± 23.025.8 ± 27.446.4 ± 33.0
From vitamin C15.3 ± 29.640.1 ± 55.299.8 ± 129.7351.6 ± 250982.1 ± 420.8
Table 3. Hazard ratios and 95% confidence intervals of mortality according to energy-adjusted dietary total antioxidant capacity.
Table 3. Hazard ratios and 95% confidence intervals of mortality according to energy-adjusted dietary total antioxidant capacity.
Energy-Adjusted Dietary Total Antioxidant Capacity (Diet + Dietary Supplements)
Quintile 1
(n = 93,746)
Quintile 2
(n = 93,747)
Quintile 3
(n = 93,747)
Quintile 4
(n = 93,747)
Quintile 5
(n = 93,746)
p for Trend
Median (range)221.2
(8.9–303)
378.9
(303–462.4)
564.9
(462.4–707.8)
893.7
(707.8–1132.4)
1543.3
(1132.4–5926.6)
All-cause mortality
Model 1 11.000.88 (0.87–0.89)0.85 (0.84–0.86)0.85 (0.84–0.86)0.83 (0.82–0.84)<0.0001
Model 2 21.000.96 (0.94–0.97)0.95 (0.94–0.96)0.96 (0.95–0.97)0.97 (0.96–0.99)0.1688
CVD mortality
Model 11.000.90 (0.88–0.92)0.88 (0.86–0.90)0.88 (0.86–0.90)0.87 (0.86–0.89)<0.0001
Model 21.000.97 (0.95–0.996)0.98 (0.95–1.00)0.99 (0.97–1.01)1.02 (0.99–1.04)0.0043
Cancer mortality
Model 11.000.85 (0.83–0.87)0.83 (0.81–0.85)0.82 (0.80–0.84)0.80 (0.78–0.82)<0.0001
Model 21.000.93 (0.91–0.95)0.92 (0.90–0.95)0.92 (0.89–0.94)0.93 (0.90–0.95)<0.0001
Energy-adjusted total antioxidant capacity from diet only
Quintile 1
(n = 93,746)
Quintile 2
(n = 93,747)
Quintile 3
(n = 93,747)
Quintile 4
(n = 93,747)
Quintile 5
(n = 93,746)
p for trend
Median (range)170.6
(8–225.4)
272
(225.4–316.3)
362.5
(316.3–414.4)
477.6
(414.4–562.8)
709.4
(562.8–3908.3)
All-cause mortality
Model 11.000.85 (0.84–0.86)0.81 (0.80–0.82)0.80 (0.79–0.81)0.80 (0.79–0.81)<0.0001
Model 21.000.93 (0.92–0.94)0.92 (0.91–0.93)0.92 (0.90–0.93)0.93 (0.92–0.94)<0.0001
CVD mortality
Model 11.000.87 (0.85–0.89)0.84 (0.82–0.86)0.84 (0.83–0.86)0.85 (0.84–0.87)<0.0001
Model 21.000.94 (0.92–0.97)0.93 (0.91–0.95)0.95 (0.93–0.98)0.97 (0.94–0.99)0.2122
Cancer mortality
Model 11.000.82 (0.80–0.84)0.78 (0.77–0.80)0.76 (0.74–0.78)0.76 (0.75–0.78)<0.0001
Model 21.000.91 (0.89–0.94)0.90 (0.88–0.92)0.88 (0.86–0.91)0.90 (0.88–0.92)<0.0001
Energy-adjusted total antioxidant capacity from dietary supplements only
Non-consumer
(n = 153,024)
Tertile 1
(n = 105,236)
Tertile 2
(n = 105,237)
Tertile 3
(n = 105,236)
p for trend
Median (range)0 (0–0)58.2 (0–103.3)276.5 (103.3–555)938 (555–3345.8)
All-cause mortality
Model 11.000.95 (0.94–0.96)0.90 (0.89–0.91)0.92 (0.91–0.93)<0.0001
Model 21.001.00 (0.99–1.01)0.99 (0.98–0.998)1.01 (0.99–1.02)0.2513
CVD mortality
Model 11.000.92 (0.90–0.94)0.91 (0.90–0.93)0.93 (0.91–0.94)<0.0001
Model 21.000.98 (0.96–0.997)1.01 (0.99–1.03)1.03 (1.01–1.05)0.0002
Cancer mortality
Model 11.000.95 (0.93–0.97)0.89 (0.87–0.90)0.91 (0.89–0.93)<0.0001
Model 21.000.99 (0.96–1.01)0.94 (0.92–0.96)0.97 (0.95–0.99)0.0190
1 Model 1 included age and sex. 2 Model 2 additionally included race/ethnicity, body mass index, marital status, alcoholic beverage intake, smoking, physical activity, history of heart disease, stroke, and diabetes, and total energy intake.
Table 4. Stratified analysis for mortality associated with energy-adjusted total antioxidant capacity from diet only.
Table 4. Stratified analysis for mortality associated with energy-adjusted total antioxidant capacity from diet only.
SubgroupNHazard Ratio (95% Confidence Interval) 1,2
All-Cause MortalityCVD MortalityCancer Mortality
Age
<65 years300,6780.95 (0.93–0.96) 11.00 (0.97–1.04)0.91 (0.88–0.94)
≥65 years168,0550.91 (0.89–0.93)0.94 (0.91–0.97)0.89 (0.85–0.92)
P for interaction <0.00010.07390.0034
Sex
Male278,3630.93 (0.92–0.95)0.98 (0.95–1.00)0.88 (0.86–0.91)
Female190,3700.93 (0.91–0.95)0.95 (0.91–0.99)0.93 (0.89–0.97)
P for interaction 0.81420.43840.4666
Body weight status
Normal357,2520.91 (0.90–0.92)0.94 (0.92–0.97)0.89 (0.87–0.92)
Obese100,3021.00 (0.97–1.03)1.05 (1.00–1.09)0.94 (0.89–0.99)
P for interaction <0.0001<0.00010.1175
Alcoholic beverage intake
None220,1450.93 (0.91–0.95)0.96 (0.92–0.99)0.91 (0.88–0.95)
Low121,7210.96 (0.93–0.98)1.01 (0.96–1.06)0.92 (0.88–0.97)
High126,8670.91 (0.89–0.93)0.95 (0.90–0.99)0.87 (0.83–0.91)
P for interaction 0.21840.07630.2140
Current smoking status
Never/former smokers395,5040.92 (0.91–0.94)0.95 (0.93–0.98)0.89 (0.86–0.91)
Current smokers55,4190.90 (0.87–0.94)0.99 (0.93–1.06)0.88 (0.83–0.93)
P for interaction 0.46750.27730.0732
1 Adjusted for age, sex (except for sex-stratified analysis), race/ethnicity, body mass index (except for body weight status-stratified analysis), marital status, alcoholic beverage intake (except for alcoholic beverage intake-stratified analysis), smoking (except for current smoking status-stratified analysis), physical activity, history of heart disease, stroke, and diabetes, and total energy intake. 2 Hazard ratios of quintile 5 compared to quintile 1 were presented.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ha, K.; Liao, L.M.; Sinha, R.; Chun, O.K. Dietary Total Antioxidant Capacity, a Diet Quality Index Predicting Mortality Risk in US Adults: Evidence from the NIH-AARP Diet and Health Study. Antioxidants 2023, 12, 1086. https://0-doi-org.brum.beds.ac.uk/10.3390/antiox12051086

AMA Style

Ha K, Liao LM, Sinha R, Chun OK. Dietary Total Antioxidant Capacity, a Diet Quality Index Predicting Mortality Risk in US Adults: Evidence from the NIH-AARP Diet and Health Study. Antioxidants. 2023; 12(5):1086. https://0-doi-org.brum.beds.ac.uk/10.3390/antiox12051086

Chicago/Turabian Style

Ha, Kyungho, Linda M. Liao, Rashmi Sinha, and Ock K. Chun. 2023. "Dietary Total Antioxidant Capacity, a Diet Quality Index Predicting Mortality Risk in US Adults: Evidence from the NIH-AARP Diet and Health Study" Antioxidants 12, no. 5: 1086. https://0-doi-org.brum.beds.ac.uk/10.3390/antiox12051086

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop